BioSpace News Archive

Since its September 2018 initial public offering (IPO), Elanco Animal Health Inc. (NYSE: ELAN) has continued to evaluate its capabilities, structure and staffing to meet its goal of being an agile, standalone company, focused exclusively on animal health and delivering on its Innovation, Portfolio and Productivity (IPP) strategy.

Centene Corporation (NYSE: CNC) announced today that David P. Thomas has been appointed Executive Vice President of Markets, for Centene, effective October 13, 2019

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced that it entered into an amended agreement related to its existing credit facility with SWK Funding LLC (“SWK”) and that it received a waiver letter from SWK related to certain financial covenants for Q3 2019.

Amoy Diagnostics Co., Ltd (AmoyDx, SZSE:300685), a leading company in companion diagnostics for precision oncology, today announced that the AmoyDx Lung Cancer PCR Panel has been accepted as first-line screening for patients who will potentially benefit from targeted therapy in the Lung Cancer Genomic Screening Project for Individualized Medicine (LC-SCRUM) in Japan.

Arete Pharmacy Network today announced that Don Meredith will assume the role of interim president, effective immediately. Meredith succeeds Rob McMahan, former chief executive officer.

Alzheimer’s Foundation of America extending weekend hours for its National Toll-Free Helpline Starting this Saturday

Cold Spring Harbor Laboratory announced a new pilot project—Transparent Review in Preprints—that enables journals and peer review services to post peer reviews of submitted manuscripts on CSHL’s preprint server bioRxiv.

Washington Hospital Healthcare System is the recipient of a three-year grant totaling $500,000 to support its expansion of palliative care services to outpatients.

The 17th Annual Parkway Run & Walk presented by Citadel raised a record-breaking $1.5 million to support childhood cancer research and care at Children’s Hospital of Philadelphia.

Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma) (Hong Kong Stock Exchange: 2607) (Shanghai Stock Exchange: 601607) has launched a new stock incentive plan (the Plan) aligned with international standards aimed at retaining and attracting talent while propelling the Chinese healthcare conglomerate into a world-class pharmaceutical innovator.